Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model

Journal of Neurosurgery

Volumn 87, Issue 5, 1997, Pages 731-737

  Kittaka, Mamoru ^a   Giannotta, Steven L ^a   Zelman, Vladimir ^a   Correale, Jorge D ^a   DeGiorgio, Christopher M ^a   Weiss, Martin H ^a   Zlokovic, Berislav V ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Cerebral blood flow; Focal ischemia; Neuron specific enolase; Neuroprotection; Nicardipine; Rat

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; ENOLASE; NICARDIPINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 0030700570     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.87.5.0731     Document Type: Article

References (51)

1. Baker AJ, Zornow MH, Scheller MS, et al: Changes in extracellular concentrations of glutamate, aspartatc, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J Neurochem 57:1370-1379, 1991
2. Barnett GH, Bose B, Little JR, et al: Effects of nimodipine on acute focal cerebral ischemia. Stroke 17:884-890, 1986
3. Barone FC, Clark RK, Price WJ, et al: Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res 623:77-82, 1993
4. Benveniste H, Drejer J, Schousboe A, et al: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374, 1984
5. Choi DW: Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58:293-297, 1985
6. Ford RW, Malm DN: Failure of nimodipine to reverse acute experimental spinal cord injury. Cent Nerv Syst Trauma 2: 9-17, 1985
7. Gelmers HJ: The effects of nimodipine on the clinical course of patients with acute ischemic stroke. Acta Neurol Scand 69: 232-239, 1984
8. Gelmers HJ, Gorter K, de Weerdt CJ, et al: A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318: 203-207, 1988
9. Gelmers HJ, Hennerici M: Effect of nimodipine on acute ischemic stroke. Pooled results from five randomized trials. Stroke 21 (Suppl 12):IV81-IV84, 1990
10. Germano IM, Bartkowski HM, Cassel ME, et al: The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings. J Neurosurg 67:81-87, 1987
11. Gotoh O, Mohamed AA, McCulloch J, et al: Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6:321-331, 1986
12. Gotti B, Duverger D, Bertin J, et al: Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia. J Pharmacol Exp Ther 247:1211-1221, 1988
13. Graham S, Shiraishi K, Panter SS, et al: Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci Lett 110:124-130, 1990
14. Hadani M, Young W, Flamm ES: Nicardipine reduces calcium accumulation and electrolyte derangements in regional cerebral ischemia in rats. Stroke 19:1125-1132, 1988
15. Hakim AM, Hogan MJ: In vivo binding of nimodipine in the brain: I. The effect of focal cerebral ischemia. J Cereb Blood Flow Metab 11:762-770, 1991
16. Harris RJ, Symon L, Branston NM, et al: Changes in extracellular calcium activity in cerebral ischemia. J Cereb Blood Flow Metab 1:203-209, 1981
17. Hatfield RH, McKernan RM: CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res 577:249-252, 1992
18. Hoffmeister F, Kazda S, Krause HP: Influence of nimodipine (Bay e 9736) on the postischemic changes of brain function. Acta Neurol Scand 60 (Suppl 72):358-359, 1979
19. Hogan MJ, Gjedde A, Hakim AM: In vivo binding of nimodipine in the brain: II. Binding kinetics in focal cerebral ischemia. J Cereb Blood Flow Metab 11:771-778, 1991
20. Kittaka M, Gianotta SL, Zelman V, et al: Nicardipine attenuates focal ischemic brain injury in rats. J Neurosurg Anesthiol 8: 332, 1996 (Abstract)
21. Kittaka M, Wang L, Sun N, et al: Brain capillary tissue plasminogen activator in diabetes stroke model. Stroke 27: 712-718, 1996
22. Longa EZ, Weinstein PR, Carlson S, et al: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91, 1989
23. Mabe H, Nagai H, Takagi T, et al: Effect of nimodipine on cerebral functional and metabolic recovery following ischemia in the rat brain. Stroke 17:501-505, 1986
24. MacDermott AB, Mayer ML, Westbrook GL, et al: NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321:519-522, 1986
25. Marzatico F, Gaetani P, Spanu G, et al: Effects of nicardipine treatment on Na+-K+ ATPase and lipid peroxidation after experimental subarachnoid haemorrhage. Acta Neurochir 108: 128-133, 1991
26. Mohamed AA, Gotoh O, Graham DI, et al: Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18:705-711, 1985
27. Morel N, Godfraind T: Cerebrovascular effect of calcium antagonists. Eur Neurol 30 (Suppl 2): 10-15, 1990
28. Nowycky MC, Fox AP, Tsien RW: Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316:440-443, 1985
29. Park CK, Nehls DG, Graham DI, et al: Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia. J Cereb Blood Flow Metab 8: 757-762, 1988
30. Park CK, Nehls DG, Teasdale GM, et al: Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 9: 617-622, 1989
31. Rod MR, Auer RN: Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia. Stroke 23:725-732, 1992
32. Roine RO, Kaste M, Kinnunen A, et al: Nimodipine after resuscitation from out-of-hospital ventricular fibrillation. A placebo-controlled, double-blind, randomized trial. JAMA 264: 3171-3177, 1990
33. Steen PA, Gisvold SE, Milde JH, et al: Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 68:406-414, 1985
34. Steen PA, Newberg LA, Milde JH, et al: Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 3: 38-43, 1983
35. Swanson RA, Morton MT, Tsao-Wu G, et al: A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293, 1990
36. Takakura S, Furuichi Y, Satoh H, et al: Effects of nilvadipine on neuronal function in the ischemic cat brain. Surg Neurol 37: 255-260, 1992
37. Takenaka T, Handa J: Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients. Int J Clin Pharmacol Biopharm 17:1-11, 1979
38. Teasdale G, Bailey I, Bell A, et al: A randomized trial of nimodipine in severe head injury: HIT I. British/Finnish Cooperative Head Injury Trial Group. J Neurotrauma 9 (Suppl 2):S545-S550, 1992
39. ++ channels: pharmacology and regulation, in Traber J, Gispen WH (eds): Nimodipine and Central Nervous System Function: New Vistas. Stuttgart, Schattauer, 1989, pp 3-16
40. Tymianski M: Cystosolic calcium concentrations and cell death in vitro, in Siesjo BK, Wieloch T (eds): Cellular and Molecular Mechanisms of Ischemic Brain Damage. Advances in Neurology, Vol 71. Philadelphia: Lippincott-Raven, 1996, pp 85-105
41. Tymianski M, Charlton MP, Carlen PL, et al: Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 13:2085-2104, 1993
42. Tymianski M, Tator CH: Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 38: 1176-1195, 1996
43. Uematsu D, Greenberg JH, Hickey WF, et al: Nimodipine attenuates both increase in cytosolic free calcium and histologic damage following focal cerebral ischemia and reperfusion in cats. Stroke 20:1531-1537, 1989
44. Uematsu D, Greenberg JH, Reivich M, et al: Direct evidence of calcium-induced ischemic and reperfusion injury. Ann Neurol 26:280-283, 1989
45. Van Reempts J, Haseldonekx M, Van Deuren B, et al: Structural damage of the ischemic brain: involvement of calcium and effects of postischemic treatment with calcium entry blockers. Drugs Dev Res 8:387-395, 1986
46. Vibulsresth S, Dietrich WD, Busto R, et al: Failure of nimodipine to prevent ischemic neuronal damage in rats. Stroke 18: 210-216, 1987
47. Wang L, Kittaka M, Sun N, et al: Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats. J Cereb Blood Flow Metab 17:136-146, 1997
48. Woodward JJ, Harms J: The putative polyamine antagonists ifenprodil and SL 82.0715 enhance dopamine efflux from rat striatal slices independent of NMDA receptor activation. Eur J Pharmacol 210:265-270, 1992
49. Yang G, Chan PH, Chen SF, et al: Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia. Neurosurgery 34:339-345, 1994
50. Zhou Z, Neher E: Mobile and immobile calcium buffers in bovine adrenal chromaffin cells. J Physiol 469:245-273, 1993
51. Zlokovic BV, McComb JG, Lipovac MN, et al: Drug transfer across the blood-brain barrier: Comparison of in vitro and in vivo models, in Drewes LR, Betz AL (eds): Frontiers in Cerebral Vascular Biology: Transport and its Regulation. Advances in Experimental Medicine and Biology, Vol 331. New York: Plenum, 1993, pp 117-121